This bill directs the Department of Veterans Affairs to establish at least five "centers of excellence" at VA medical facilities to research and provide innovative therapies—including substances like psilocybin, ketamine, and MDMA—for treating conditions such as PTSD, depression, chronic pain, and substance use disorder among veterans. Each designated center must be affiliated with accredited medical schools and include veteran advisory committees, and the VA will distribute these facilities geographically across the country based on competitive peer review of proposals. The bill authorizes $30 million annually specifically for the centers' research and education activities, with additional funding available from existing VA budgets, and requires the VA to submit annual reports to Congress detailing the centers' findings and recommendations for improving treatment delivery to veterans. The legislation sets no specific implementation timeline beyond requiring the first report within two years of enactment.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.